Coverage
-
January 16, 2018
Tweaks to a generic opioid's labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston court hearing Tuesday.
2 other articles on this case.
View all »